Filing Details

Accession Number:
0001127602-22-018293
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-30 17:00:11
Reporting Period:
2022-06-28
Accepted Time:
2022-06-30 17:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412221 M Thomas Moriarty One Cvs Drive
Woonsocket RI 02895
Evp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-28 49,279 $58.35 675,552 No 4 M Direct
Common Stock Disposition 2022-06-28 49,279 $95.00 626,273 No 4 S Direct
Common Stock Acquisiton 2022-06-28 50,502 $54.19 676,775 No 4 M Direct
Common Stock Disposition 2022-06-28 50,502 $95.00 626,273 No 4 S Direct
Common Stock Acquisiton 2022-06-28 38,873 $74.30 665,146 No 4 M Direct
Common Stock Disposition 2022-06-28 38,873 $95.00 626,273 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2022-06-28 49,279 $0.00 49,279 $58.34
Common Stock Stock Option Disposition 2022-06-28 50,502 $0.00 50,502 $54.19
Common Stock Stock Option Disposition 2022-06-28 38,873 $0.00 38,873 $74.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
98,558 2021-04-01 2030-04-01 No 4 M Direct
50,502 2020-04-01 2029-04-01 No 4 M Direct
116,622 2022-04-01 2031-04-01 No 4 M Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan.
  2. The number of shares subject to the option were calculated using a 30-day average price.
  3. Option became exercisable in four equal annual installments, commencing 4/1/2021.
  4. Option became exercisable in four equal annual installments, commencing 4/1/2020.
  5. Option became exercisable in four equal annual installments, commencing 4/1/2022.